Muzammil Ali

761 total citations · 1 hit paper
15 papers, 531 citations indexed

About

Muzammil Ali is a scholar working on Surgery, Epidemiology and Immunology. According to data from OpenAlex, Muzammil Ali has authored 15 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Muzammil Ali's work include Influenza Virus Research Studies (3 papers), interferon and immune responses (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Muzammil Ali is often cited by papers focused on Influenza Virus Research Studies (3 papers), interferon and immune responses (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Muzammil Ali collaborates with scholars based in United States, Japan and Canada. Muzammil Ali's co-authors include Mohammad Madjid, Mehran Haidari, S. Ward Casscells, Zhenping Chen, James T. Willerson, Deborah Vela, Silvio Litovsky, Philip R. Wyde, Wei Zhang and Lorraine Frazier and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Muzammil Ali

15 papers receiving 508 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial

2024 51 citations Howard A. Burris, Takuji Okusaka et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muzammil Ali United States	10	128	119	99	98	91	15	531
Christopher Wai‐Kei Lam Hong Kong	12	72 0.6×	85 0.7×	91 0.9×	41 0.4×	69 0.8×	12	784
Niamh O’Kennedy United Kingdom	13	85 0.7×	74 0.6×	269 2.7×	139 1.4×	151 1.7×	20	815
Prakash B Desai India	8	104 0.8×	37 0.3×	138 1.4×	48 0.5×	58 0.6×	9	740
Xichun Pan China	17	88 0.7×	117 1.0×	291 2.9×	65 0.7×	20 0.2×	32	744
Shivaraj Gowda India	7	108 0.8×	29 0.2×	131 1.3×	61 0.6×	54 0.6×	11	686
Yuhong Guo China	17	192 1.5×	119 1.0×	263 2.7×	41 0.4×	52 0.6×	45	752
Prema Gurumurthy India	16	237 1.9×	39 0.3×	107 1.1×	92 0.9×	27 0.3×	40	802
Yanyan Cen China	17	75 0.6×	124 1.0×	241 2.4×	71 0.7×	16 0.2×	23	632
Avinash Math India	5	102 0.8×	30 0.3×	123 1.2×	46 0.5×	53 0.6×	8	644

Countries citing papers authored by Muzammil Ali

Since Specialization

Citations

This map shows the geographic impact of Muzammil Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzammil Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzammil Ali more than expected).

Fields of papers citing papers by Muzammil Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzammil Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzammil Ali. The network helps show where Muzammil Ali may publish in the future.

Co-authorship network of co-authors of Muzammil Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Muzammil Ali. A scholar is included among the top collaborators of Muzammil Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzammil Ali. Muzammil Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Burris, Howard A., Takuji Okusaka, Arndt Vogel, et al.. (2024). Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology. 25(5). 626–635. 51 indexed citations breakdown →

Bergamini, Cristiana, Robert L. Ferris, Jing Xie, et al.. (2021). Bleeding complications in patients with squamous cell carcinoma of the head and neck. Head & Neck. 43(9). 2844–2858. 11 indexed citations

Haidari, Mehran, et al.. (2011). Inhibition of MLC Phosphorylation Restricts Replication of Influenza Virus—A Mechanism of Action for Anti-Influenza Agents. PLoS ONE. 6(6). e21444–e21444. 34 indexed citations

Ali, Muzammil, et al.. (2010). Oligonol a low molecular weight polyphenol of lychee fruit extract inhibits proliferation of influenza virus by blocking reactive oxygen species-dependent ERK phosphorylation. Phytomedicine. 17(13). 1047–1056. 36 indexed citations

Haidari, Mehran, et al.. (2010). Increased oxidative stress in atherosclerosis-predisposed regions of the mouse aorta. Life Sciences. 87(3-4). 100–110. 26 indexed citations

Madjid, Mohammad, Muzammil Ali, & James T. Willerson. (2010). Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.. PubMed. 37(1). 25–39. 34 indexed citations

Haidari, Mehran, Philip R. Wyde, Silvio Litovsky, et al.. (2009). Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis. 208(1). 90–96. 77 indexed citations

Ali, Muzammil & Mohammad Madjid. (2009). Lipoprotein-Associated Phospholipase A2: A Cardiovascular Risk Predictor and a Potential Therapeutic Target. Future Cardiology. 5(2). 159–173. 21 indexed citations

Haidari, Mehran, Muzammil Ali, S. Ward Casscells, & Mohammad Madjid. (2009). Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine. 16(12). 1127–1136. 188 indexed citations

10.

Haidari, Mehran, Muzammil Ali, S. Ward Casscells, & Mohammad Madjid. (2007). Abstract 147: Statins Block Influenza Infection By Down-regulating Rho/rho Kinase Pathway. Circulation. 116. 3 indexed citations

11.

Carillio, Guido, et al.. (2007). Association of weekly gemcitabine to conformal radiotherapy as organ-sparing strategy in locally advanced or relapsed bladder cancer. Journal of Clinical Oncology. 25(18_suppl). 15570–15570. 1 indexed citations

12.

Madjid, Mohammad, et al.. (2005). Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opinion on Biological Therapy. 5(1). 91–96. 32 indexed citations

13.

Morice, Rodolfo C., G. Walsh, Muzammil Ali, & Jan Roth. (1996). Redefining the lowest exercise peak oxygen consumption acceptable for lung resection of high risk patients. 110. 8 indexed citations

14.

Ewer, Michael S., Muzammil Ali, Harry R. Gibbs, & Joseph Swafford. (1992). Nodus migrans: the case of the migrating knot.. PubMed. 1(2). 108–10. 6 indexed citations

15.

Gibbs, Harry R., Joseph Swafford, Michael S. Ewer, & Muzammil Ali. (1992). Cardiac emergencies in the cancer patient.. PubMed. 6(10). 25–9; discussion 29. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact